Explainer

High-Functioning Depression: Signs, Diagnosis and the Evidence

High-functioning depression is not a DSM diagnosis. In 2024, 6.7 million U.S. adults had major depression without severe impairment. What the research shows.

Mental Health Stats Research Team 8 min read

Key Takeaways

  • High-functioning depression is not a diagnosis in DSM-5 or ICD-11; it is an informal label for depressive symptoms that persist while work, school and family roles are kept up[9].Not in DSM-5[9]
  • In 2024, 21.4 million U.S. adults (8.2%) had a major depressive episode, and 14.7 million (5.6%) had one with severe impairment, so about 6.7 million did not meet the severe-impairment threshold[1].6.7 million[1]
  • Persistent depressive disorder, the formal diagnosis the term most often overlaps with, requires depressed mood on more days than not for at least 2 years[4].2 years[4]
  • In a 2003 study of U.S. workers, 81% of the lost productive time costs tied to depression came from reduced performance while at work rather than absence[7].81%[7]
  • In a 10-year follow-up of adults with early-onset dysthymia, 95.1% had a major depressive episode at some point by the end of the study[6].95.1%[6]
How these numbers are measured: Because high-functioning depression has no diagnostic criteria, no national survey counts it directly. The figures below use two proxies: adults whose major depressive episode did not reach the "severe impairment" level on the Sheehan Disability Scale in SAMHSA's National Survey on Drug Use and Health[2], and persistent depressive disorder, measured in the National Comorbidity Survey Replication in 2001 to 2003[3].

What Is High-Functioning Depression?

High functioning depression describes a person who has ongoing symptoms of depression, such as low mood, fatigue and emotional exhaustion, while still meeting professional, academic or family obligations[9]. It is not a formal diagnosis in DSM-5 or ICD-11[9].

The term sits inside the broader picture of depression. In diagnostic terms it overlaps most with persistent depressive disorder (PDD), a chronic, lower-grade form[9], though people with major depressive disorder can also keep functioning outwardly.

A 2025 commentary in BJPsych Bulletin describes the label as closely overlapping with persistent depressive disorder, but with fewer observable functional impairments[9]. The same authors note that the internal distress is often unnoticed, misattributed or suppressed because outward performance looks normal[9].

Persistent depressive disorder (PDD)

A DSM-5-TR depressive disorder defined by a period of 2 years or longer of depressed mood, most of the day, for more days than not[4]. Two or more of the following are also present: hopelessness, sleeping too little or too much, low energy, low self-esteem, poor appetite or overeating, and poor concentration[5]. In children and teens the mood can be irritable rather than sad, and the minimum is 1 year[5].

Related Terms

dysthymia
chronic depression
double depression
high-functioning depression

Source: American Psychiatric Association (DSM-5-TR); MedlinePlus

Is High-Functioning Depression a Real Diagnosis?

No. There is no code, symptom count or duration rule for high-functioning depression. The BJPsych Bulletin authors call it diagnostically undefined and describe it as a blind spot created by a culture that equates visible functioning with mental wellness[9].

The closest formal diagnosis has been redefined twice[4]. DSM-IV's dysthymic disorder capped severity by excluding anyone who met criteria for a major depressive episode during the first 2 years[4]. DSM-5 merged it into persistent depressive disorder, and DSM-5-TR dropped the word "dysthymia" from the name entirely[4].

That history matters for the "high-functioning" idea. Every DSM-IV case of dysthymia counts as PDD today, but not every case of PDD would have qualified as dysthymia, because PDD can include full major depressive episodes[4].

Direct research on the label is new and small. A 2025 study in Cureus that set out to characterize its clinical correlates interviewed 120 adults and reported higher anhedonia and trauma scores among those scoring higher for high-functioning depression[8]. The scales used carry the lead author's name and the sample was small, so the findings are preliminary.

Signs of High-Functioning Depression

The signs are the symptoms of depression itself, minus the visible collapse. The 2025 Cureus study defined the presentation as fatigue, anhedonia, poor concentration, guilt, restlessness, sleep disturbance and appetite change without a lack of functioning or significant distress[8].

Clinical commentary adds a behavioral layer. People in this group often describe themselves as "just tired" or "coping under pressure," and clinicians may misattribute the signs to occupational stress, perfectionism or situational burnout[9].

  • Low, dark or sad mood on most days, for at least 2 years in adults[5].
  • Low energy or fatigue[5].
  • Low self-esteem and a negative view of oneself, the future and other people[5].
  • Sleep and appetite changes in either direction[5].
  • Poor concentration and feelings of hopelessness[5].
  • Irritability and emotional detachment behind a composed public face[9].

The difference from ordinary sadness is persistence and spread across life areas. The site's guide to depression vs. sadness covers that line in more detail.

High-Functioning Depression vs. Persistent Depressive Disorder vs. Major Depression

FeatureHigh-functioning depressionPersistent depressive disorderMajor depressive episode
Formal diagnosisNoYes (DSM-5-TR)Yes (DSM-5-TR)
Minimum durationNone defined2 years (1 year in youth)2 weeks
Core symptomVariesDepressed mood more days than notDepressed mood or loss of interest
Other symptoms requiredNone defined2 or moreA majority of specified symptoms
FunctioningOutwardly preservedMild to serious impairmentOften impaired; severe in most

How the informal label compares with the two recognized diagnoses it overlaps with. PDD criteria from the APA and MedlinePlus[4][5]; major depressive episode definition from NIMH[2].

1"Severe in most" reflects 2024 NSDUH data: 14.7 million of 21.4 million U.S. adults with a past-year major depressive episode had severe impairment[1].

2PDD impairment range is from NCS-R data collected in 2001 to 2003 under DSM-IV dysthymia criteria[3].

Sources

  • •APA, 2022
  • •MedlinePlus, 2026
  • •NIMH, 2023
  • •SAMHSA, 2025

How Many People Keep Functioning Through Depression?

No survey asks about high-functioning depression, but federal data show that a large minority of adults with major depression do not report severe impairment. In 2024, 21.4 million U.S. adults (8.2%) had a past-year major depressive episode, and 14.7 million (5.6%) had one with severe impairment[1]. That leaves about 6.7 million adults, roughly 3 in 10, whose episode did not reach the severe-impairment level (mhstats calculation from SAMHSA figures)[1].

"Severe impairment" has a specific meaning in this survey. Respondents rate how much depression interfered with home management, work, close relationships and social life on the Sheehan Disability Scale from 0 to 10, and a rating of 7 or more in at least one domain counts as severe[2]. Someone below that line can still have significant symptoms.

Treatment rates follow the same split. In 2021, 61.0% of adults with a major depressive episode received treatment, compared with 74.8% of those with severe impairment[2]. Working from those NIMH figures, roughly 30% of adults whose episode was not severe received treatment that year (mhstats estimate from rounded figures)[2].

For persistent depressive disorder, the most recent national estimate is old. The National Comorbidity Survey Replication, fielded from 2001 to 2003, found 1.5% of U.S. adults had the disorder in the past year; 18.2% of those cases were rated mild and 32.1% moderate on the Sheehan scale[3]. Current prevalence figures are on the depression statistics page.

Share of depression-related lost work time costs caused by reduced performance on the job, not absence
81%

Most of the economic cost of depression in U.S. workers was invisible: it came from people who were at work but working below capacity. The data are from 2003, before current remote and hybrid work patterns.

"Eighty-one percent of the LPT costs are explained by reduced performance while at work."

Stewart WF, et al. (JAMA)(2003) View Source

The Hidden Cost: Presenteeism at Work

Workplace research offers one measurable sign that depression can hide behind normal attendance. In a 2003 JAMA study of U.S. workers, those with depression lost a mean of 5.6 hours of productive time per week, against an expected 1.5 hours without depression[7].

Most of that loss happened on the job. Reduced performance while at work explained 81% of the lost productive time costs, which the authors estimated at $44 billion per year in 2002 dollars[7]. Workers with dysthymia averaged 2.7 hours of reduced on-the-job performance per week, compared with an expected 1.1 hours, while their absence was close to the expected level (0.5 vs. 0.4 hours)[7].

That pattern, showing up but working at reduced capacity, is the measurable version of what "high-functioning" describes. More workplace data are in the guide to mental health in the workplace.

Can High-Functioning Depression Get Worse?

The research on chronic, lower-grade depression shows a high risk of escalation. When a major depressive episode develops on top of dysthymia, it is called double depression, and more than 75% of people with dysthymic disorder have such exacerbations, according to earlier research summarized by Klein and colleagues[6].

Their 10-year study followed 97 outpatients with early-onset dysthymic disorder[6]. By the end of follow-up, 95.1% of the patients with dysthymia had experienced a major depressive episode at some point in their lives[6]. Among those who entered with no such history, the estimated 10-year risk of a first episode was 82.6%[6].

Recovery was common but slow. The estimated recovery rate was 73.9%, with a median time to recovery of 52 months, and 71.4% of those who recovered relapsed into another period of chronic depression[6]. These were treatment-seeking outpatients, so the figures may not describe people who never come to clinical attention.

Persistent depressive disorder also increases the risk of suicide, according to the National Library of Medicine[5]. The BJPsych Bulletin authors warn that delayed recognition can mean a person first reaches care in crisis or through physical complaints[9].

How High-Functioning Depression Is Screened and Diagnosed

Because the label is informal, a clinician evaluates for recognized depressive disorders instead. The U.S. Preventive Services Task Force recommends screening all adults for depression, including pregnant and postpartum people and older adults (grade B, 2023)[10].

The Patient Health Questionnaire is the most common tool. At the standard cutoff of 10, the PHQ-9 identified 85% of people with major depression and 85% of those without it compared with a semistructured interview; the two-item PHQ-2 caught 91% of cases but correctly cleared only 67% of people without depression[10].

Those numbers describe major depression, not the subthreshold, long-running pattern. The BJPsych Bulletin authors argue that the PHQ-9 and GAD-7 may miss persistent symptoms in people who minimize their distress[9]. A full evaluation includes a history of mood over time, and a provider may order blood and urine tests to check for medical causes[5].

How High-Functioning Depression Is Treated

Treatment follows the evidence for the diagnosis a clinician makes, such as persistent depressive disorder. A Cochrane review of 29 trials found antidepressants more effective than placebo for dysthymia, with no meaningful differences between drug classes[11]. The number needed to treat was 5 for SSRIs and 4.3 for tricyclic antidepressants, and tricyclics caused more side effects and dropouts[11].

The reviewers rated the quality of the trial reports as poor, and long-term data were limited[11].

The National Library of Medicine notes that medicines for PDD sometimes do not work as well as they do for major depression and may take longer to work[5]. Talk therapy, including cognitive behavioral therapy and insight-oriented psychotherapy, is also used[5].

Combining the two has modest measured benefits. A 2012 meta-analysis of 8 trials with 1,618 participants with chronic depression found a small, statistically non-significant advantage for combined treatment over medication alone on depression outcomes (benefit ratio 1.20), and a small significant gain in quality of life (SMD 0.18)[12].

Engagement is a specific problem in this group. Patients may question whether they deserve help, feel guilt for seeking care, or stop therapy once their outward performance improves[9]. For family members and partners, the site's guide on how to help someone with depression summarizes what the research shows.

Frequently Asked Questions

Sources & References

  1. Substance Abuse and Mental Health Services Administration. Release of the 2024 National Survey on Drug Use and Health: Leveraging the Latest Substance Use and Mental Health Data to Make America Healthy Again. SAMHSA. Published 2025. Accessed October 2026. https://www.samhsa.gov/blog/release-2024-nsduh-leveraging-latest-substance-use-mental-health-data-make-america-healthy-again [Link]
  2. National Institute of Mental Health. Major Depression. National Institutes of Health. Published 2023. Accessed October 2026. https://www.nimh.nih.gov/health/statistics/major-depression [Link]
  3. National Institute of Mental Health. Persistent Depressive Disorder (Dysthymic Disorder). National Institutes of Health. Accessed October 2026. https://www.nimh.nih.gov/health/statistics/persistent-depressive-disorder-dysthymic-disorder [Link]
  4. American Psychiatric Association. Persistent Depressive Disorder (DSM-5-TR fact sheet). American Psychiatric Association. Published 2022. Accessed October 2026. https://www.psychiatry.org/getmedia/fd3dfaad-d409-4e94-8605-0350adec5b91/APA-DSM5TR-PersistentDepressive.pdf [Link]
  5. MedlinePlus Medical Encyclopedia. Persistent depressive disorder. National Library of Medicine. Published 2026. Accessed October 2026. https://medlineplus.gov/ency/article/000918.htm [Link]
  6. Klein DN, Shankman SA, Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. American Journal of Psychiatry. Published 2006. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/ajp.2006.163.5.872 [Link]
  7. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. Published 2003. Accessed October 2026. https://jamanetwork.com/journals/jama/fullarticle/196767 [Link]
  8. Joseph JF, Tural U, Joseph ND, et al. Understanding high-functioning depression in adults. Cureus. Published 2025. Accessed October 2026. https://www.cureus.com/articles/322152-understanding-high-functioning-depression-in-adults [Link]
  9. Okereke PU, Umeh CV, Okereke WO, et al. High-functioning depression: a hidden burden demanding clinical recognition. BJPsych Bulletin. Published 2025. Accessed October 2026. https://www.cambridge.org/core/journals/bjpsych-bulletin/article/highfunctioning-depression-a-hidden-burden-demanding-clinical-recognition/5AE1AF5B7583F38C0DBDF1875D705E5C [Link]
  10. US Preventive Services Task Force. Depression and Suicide Risk in Adults: Screening. USPSTF. Published 2023. Accessed October 2026. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults [Link]
  11. Silva de Lima M, Moncrieff J, Soares B. Drugs versus placebo for dysthymia. Cochrane Database of Systematic Reviews. Published 2005. Accessed October 2026. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001130/full [Link]
  12. von Wolff A, Hölzel LP, Westphal A, Härter M, Kriston L. Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: a systematic review and meta-analysis. BMC Psychiatry. Published 2012. Accessed October 2026. https://link.springer.com/article/10.1186/1471-244X-12-61 [Link]

Related Statistics